Anti Tumorintermediate Raw Materials CAS 97614-43-2

Name: Anti Tumorintermediate Raw Materials CAS 97614-43-2
Brand: Shandong Yifan Chemical Technology Co., Ltd.
SKU: 2061313352

Shandong, ChinaShandong Yifan Chemical Technology Co., Ltd.

US$10.00-100.00

1 kg

Sample price:US$100.00/kg.Request sample

Product profile

CAS No.

97614-43-2

Formula

97614-43-2

Type

Synthesis Material Intermediates

Model NO.

CAS 97614-43-2

Quality

Industrial

Colour

Colorless

Purity

99%

Package

200kg, 25kg

Delivery Time

48 Hours

Color

as Pic

Stock

in Stock

Transport Package

200kg 25kg

Trademark

Yifan Chem

Origin

Shandong China

Production Capacity

50000kg/Mouth

Company profile

Importers and ExportersHigh Repeat Buyers Choice

Shandong Yifan Chemical Technology Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory, Trading CompanyAverage Response Time: ≤0.66h

AI-Powered supplier vetting

SummaryThe supplier operates across textile, biobased-material, daily chemical, engineering research, biomass-fuel process R&D, and basic chemical raw-material manufacturing activities. It offers sample-based and minor customization, but reports no new products in the past year, no ODM service, no SDK, and no OEM service for popular brands. Quality assurance and raw-material traceability are stated, while finished products are checked by packing staff. The supplier reports ISO-related and other management-system certifications and exports to more than 17 countries, but has no overseas agents, branches, warehouses, showrooms, or offline trade-show participation. After-sales corrective-action and complaint-handling procedures are undocumented. Financial evidence is incomplete and includes stated zero profit figures; financial credibility therefore cannot be fully established.

Supplier typeThe supplier’s stated business scope covers textile and textile raw materials, biobased materials, daily chemical products, engineering and technical research, biomass liquid-fuel process R&D, and basic chemical raw-material manufacturing. It also states that its goods are exported to more than 17 countries, indicating a manufacturing and export-oriented supplier profile.

CertificationsThe supplier lists ISO 9000, ISO 9001, ISO 14001, ISO 14000, ISO 20000, OHSAS/OHSMS 18001, HSE, GMP, ISO 14064, and QC 080000 certifications or systems, and states that production complies with ISO 9001 and ISO 2000 standards. The slices explicitly support substantial certification-system coverage.

After-Sales capabilityThe supplier reports no written procedures or records for corrective and preventive actions or for effective customer-complaint handling. Although quality assurance is stated, the absence of documented after-sales mechanisms is a specific service-process deficiency.

R&D capabilityThe supplier reports no new products in the past year, no ODM service, and no available SDK. Its business scope mentions engineering research and biomass-fuel process R&D, but the explicit product-development and SDK evidence indicates limited demonstrated innovation capability.

Production capacityThe supplier states that it manufactures basic chemical raw materials and operates production processes supported by advanced technology and testing methods. It also reports quality assurance, raw-material traceability, and exports to more than 17 countries; however, finished-product inspection is performed by packing staff, so the evidence supports production activity and basic controls rather than a fully documented advanced production system.

Customization capabilityThe supplier explicitly provides customization from samples and minor customization. However, it does not provide ODM services or OEM services for popular brands, so its customization capability is limited to sample-based and minor adjustments.

Client casesThe supplier states that its goods have been exported to more than 17 countries across Europe, the Americas, the Middle East, Asia Pacific, and Africa. It also explicitly reports no cooperation with Fortune 500 companies, so geographic export experience is evidenced but named major-customer cases are not.